IBB

Biotech May be Bargain Hunters’ Next Target

Buyers seem to be focused on only the most beaten-down sectors. More 

iShares Nasdaq Biotechnology Index (ETF) (IBB): Nibble on the Long Side

Biotech stocks, after some prolonged weakness, are starting to show promising relative and absolute strength. That means opportunity in the IBB. More 

3 Biotech Stocks on the Verge of an Overdue Run (AMGN, GILD, REGN)

Biotech stocks are making a comeback, with these three biotech beauties boasting bottoming patterns suggesting the time to strike is at hand. More 

Trade of the Day: iShares Nasdaq Biotechnology Index (ETF) (NASDAQ:IBB)

The Health Care ETF (IHF) broke down like a rented mule in early February following the breach of $110. Use IBB to trade this trend in biotech. More 

This Big Biotech ETF Faces a Key Technical Test

Those who follow our blog know we are proponents of technical analysis in reading the trends of the market. A trend in this biotech ETF suggests opportunity More 

8 Stocks and ETFs Your Financial Advisor Is Buying Right Now

What are the best stocks to buy right now? We try to answer this question by tracking the moves of smart money and buy side analysts. Here's what's hot... More 

The iShares Nasdaq Biotechnology Index (ETF) (IBB) Is a Buy, But Not for Long

The iShares Nasdaq Biotechnology ETF (IBB) has yet to pull off something that other parts of the market have -- and that spells opportunity in IBB. More